Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII™

Bausch Health, Canada, has announced that Health Canada has approved the use of DUOBRII™ lotion, a topical prescription medicine used to improve the signs and symptoms of plaque psoriasis in adult patients with moderate to severe plaque psoriasis.

DUBROII is the first and only complementary retinoid-steroid combination of two ingredients, one which helps the inflammation associated with psoriasis and one which helps the normal growth of skin cells and reduces inflammation.